English
简体中文
Total: £ 56.28
2026-04-07 | Pages: 158 | Tables: 165
The global Angiogenesis Modulators market was valued at US$ 19800 million in 2025 and is anticipated to reach US$ 29621 million by 2032, at a CAGR of 5.9% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ...
2026-04-02 | Pages: 123 | Tables: 121
The global Menstrual Regulating Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lands...
2026-04-02 | Pages: 100 | Tables: 94
The global Medroxyprogesterone Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lan...
2026-04-02 | Pages: 93 | Tables: 99
The global Kun Bao Wan market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This rep...
2026-04-02 | Pages: 110 | Tables: 104
The global Chronic Hepatitis C Treatment Oral Medicine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Chronic Hepatitis C Treatment Oral Medicine...
2026-04-02 | Pages: 114 | Tables: 111
The global Perfluorodecalin for Ophthalmic Surgery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ...
2026-04-02 | Pages: 119 | Tables: 127
The global Vinca Alkaloid market was valued at US$ 133 million in 2025 and is anticipated to reach US$ 215 million by 2032, at a CAGR of 7.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-04-02 | Pages: 115 | Tables: 110
The global Nanomaterial-Based Adjuvants Vaccine market was valued at US$ 355310 million in 2025 and is anticipated to reach US$ 670310 million by 2032, at a CAGR of 9.6% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty i...
2026-04-02 | Pages: 113 | Tables: 111
The global Cattle Vaccine market was valued at US$ 1780 million in 2025 and is anticipated to reach US$ 2723 million by 2032, at a CAGR of 6.4% from 2026 to 2032.A cattle vaccine is a biological preparation designed to help cattle (both beef and dair...
2026-04-02 | Pages: 118 | Tables: 124
The global Pets Anti-infective Drugs market was valued at US$ 2434 million in 2025 and is anticipated to reach US$ 7185 million by 2032, at a CAGR of 17.0% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global...
2026-04-02 | Pages: 98 | Tables: 98
The global Ranibizumab market was valued at US$ 2555 million in 2025 and is anticipated to reach US$ 1245 million by 2032, at a CAGR of -9.9% from 2026 to 2032.Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fra...
2026-04-02 | Pages: 124 | Tables: 125
The global OTC Anti-Infective Products market was valued at US$ 14670 million in 2025 and is anticipated to reach US$ 18480 million by 2032, at a CAGR of 3.4% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glo...
2026-04-02 | Pages: 122 | Tables: 137
The global Follicular Lymphoma Drugs market was valued at US$ 2103 million in 2025 and is anticipated to reach US$ 3442 million by 2032, at a CAGR of 7.4% from 2026 to 2032.Follicular lymphoma is a cancer that affects white blood cells called lymphoc...
2026-04-02 | Pages: 113 | Tables: 112
The global Pharma-Grade Hyaluronic Acid market was valued at US$ 221 million in 2025 and is anticipated to reach US$ 436 million by 2032, at a CAGR of 10.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the globa...
2026-04-02 | Pages: 117 | Tables: 109
The global Animal Lipase market was valued at US$ 107 million in 2025 and is anticipated to reach US$ 138 million by 2032, at a CAGR of 3.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lands...
